Until a few years ago, amyloid plaques in the brains of patients with Alzheimer's disease could only be demonstrated by means of neuropathological examination. New PET tracers allow for visualisation of these amyloid plaques in living patients. Biological validity and clinical relevance of this technique have been established. Expertise in interpretation of the images and the diagnostic impact is required. Cost effectiveness and added value over existing methods in terms of diagnosis and prognosis are still being investigated.
|Translated title of the contribution||Amyloid PET imaging in patients with Alzheimer's disease|
|Journal||Nederlands Tijdschrift voor Geneeskunde|
|Publication status||Published - 2017|